Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3674176012 | Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3674177015 | Carbamazepine 100 mg chewable tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4591461000052110 | karbamazepin 100 milligram, tuggtablett | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Is a | Product containing carbamazepine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Is a | Product containing carbamazepine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Has active ingredient | Carbamazepine - chemical | false | Inferred relationship | Some | ||
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Has active ingredient | Carbazepine antiepileptic (substance) | false | Inferred relationship | Some | ||
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Has active ingredient | Carbamazepine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Has manufactured dose form | Chewable tablet | true | Inferred relationship | Some | ||
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Has basis of strength substance (attribute) | Carbamazepine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | har täljarvärde som visar styrka | 100 | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Has precise active ingredient | Carbamazepine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | räkning av bas i aktiv ingrediens | 1 (qualifier value) | false | Inferred relationship | Some | ||
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Is a | Carbamazepine only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Plays role | Anticonvulsant therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR